What is AfterOurs?
AfterOurs operates as a specialized urgent care provider that functions as a strategic extension of the traditional family medical practice. Unlike conventional urgent care facilities that may compete with primary care physicians, AfterOurs is designed to complement existing medical infrastructure. The company explicitly avoids managing chronic conditions like diabetes or providing routine preventative care such as vaccinations and annual physicals. Instead, it focuses on acute, non-life-threatening injuries and illnesses, acting as a triage point that directs patients back to their primary care providers. This symbiotic relationship is reinforced by a robust referral system, where AfterOurs facilitates thousands of patient connections to primary care offices and specialists, effectively acting as a lead generator for the broader medical community. By prioritizing the continuity of care, the company ensures that medical records are seamlessly transferred to primary physicians, thereby enhancing the overall quality of patient outcomes.
How much funding has AfterOurs raised?
AfterOurs has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in AfterOurs
PPP
Public-Private Partnership
What's next for AfterOurs?
With the recent influx of capital, AfterOurs is well-positioned to accelerate its strategic growth initiatives. The company is expected to leverage this investment to expand its clinical footprint and enhance its referral technology, which is central to its value proposition. By deepening its integration with local healthcare providers, AfterOurs aims to solidify its reputation as a reliable partner in the medical ecosystem. Future developments will likely focus on optimizing patient flow and strengthening the digital infrastructure required to manage the high volume of referrals. As the firm matures, its ability to maintain this collaborative model will be key to sustaining its market share and ensuring long-term viability in an increasingly fragmented healthcare market.
See full AfterOurs company page
